key: cord-0832644-hxqpaeva authors: Abdulrahman, A.; Albastaki, A.; AlAwadhi, A. I.; AlWazzan, A.; AlQahtani, M. title: Diagnostic and monitoring utilities of saliva for SARS-CoV-2 date: 2020-12-07 journal: nan DOI: 10.1101/2020.12.07.20244681 sha: 7ec68d6d3d99811ba7a2dd86c26aaa8e97ca9d2b doc_id: 832644 cord_uid: hxqpaeva Introduction Nasopharyngeal (NP) swab is an invasive procedure that is difficult to perform in pediatric cases and those with special needs. On the other hand, saliva has been a proposed sample given the ease of collection, comfort and the ability to self-collect. The research project aims to study the presence of SARS-CoV-2 in the saliva of suspected COVID-19 patients in comparison to its presence in NP swabs. Methodology A cross-sectional study was conducted in October 2020 in COVID19 clinic in the Bahrain Defense Force Hospital. The study compared the presence of SARS-CoV2 by PCR in saliva samples to nasopharyngeal samples. COVID-19 Clinic tests symptomatic, staff, close contacts and pre-operation patients. Results The saliva PCR has shown a sensitivity of 72.9% (95% CI: 58.2% - 84.7%) and a specificity of 98.8% (95% CI: 97.8% - 99.4%). The PPV was 74.5% (95% CI 59.7% to 86.1%) and the NPV was 98.6% (95% CI 97.7% to 99.3%). Kappa coefficient of agreement between saliva and NP was 0.723 (95% CI 0.62 to 0.82, p<0.001). Moreover, when restricting cases to symptomatic only, the sensitivity of saliva increased to 86.7% (95% CI 59.5% to 98.3%) while specificity remained high at 97.2%. Conclusion The findings of the study suggest that saliva samples have the potential to be used as a screening tool for SARS-CoV-2, especially in symptomatic individuals. This is especially important when it is difficult to collect NP samples. Saliva samples are however at risk of producing more false negative tests. The first case of novel corona virus (SARS-CoV-2) was discovered in late December 2019; a new string of the disease that causes coronavirus disease 2019 (COVID- 19) , which occurred in Wuhan city, China. The disease has spread rapidly across the globe that it was declared by the world health organization (WHO) as a pandemic. [1] [2] [3] [4] . COVID-19 is an upper respiratory tract infection that is mainly spread through saliva droplets and nasal discharges while coughing or sneezing [5] . The disease symptoms include fever, cough, shortness of breath, myalgias, fatigue, loss of smell and taste [6] . Due to the high transmission rate of the disease, many countries are embracing strict activity restrictions and implemented lockdowns and curfews in an attempt to reduce the infection rate. Detection and isolation of infected individuals are essential actions in deescalating the disease transmission [7, 8] . Variety of SARS-CoV-2 detection methods are available;, nasopharyngeal swab (NP) has been the preferred specimen for polymerase chain reaction (PCR) testing due to its high detection accuracy [2, 9, 10] . The NP swab has several disadvantages; its invasive, painful, aerosolizing and increases risk of exposure by the healthcare worker. On the other hand, saliva has been a proposed as a diagnostic sample given the ease of collection, comfort and the ability to self-collect. The possibility of self-collection reduces the risk of exposure of healthcare workers and hence can be a safer option [11] . It was proposed that there are at least three pathways for SARS-CoV-2 to be present in the saliva. First, the virus enters the oral cavity from the upper and lower respiratory tract through the liquid droplets that are frequently exchanged between these tracts. Secondly, SARS-CoV-2 in the blood can access the oral cavity via crevicular fluid, an oral cavity-specific exudate that contains local proteins derived from extracellular matrix and serum-derived proteins Third, is by salivary gland infection, with subsequent release of particles in saliva via salivary ducts. It is essential to point out that salivary gland epithelial cells can be infected by SARS-CoV a short time after infection in rhesus macaques, suggesting that salivary gland cells could be a pivotal source of this virus in saliva [12] . However, there have been conflicting studies on the presence of SARS-CoV2 virus in the saliva sample of infected patients [1] [2] [3] [4] 8, 13] . Thus, this research . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted December 7, 2020. ; project aims to study the presence of SARS-CoV-2 in the saliva of suspected COVID-19 patients in comparison to its presence in NP swabs. This can help guide testing saliva as a screening tool for COVID-19. Determining the presence of SARS-CoV-2 by RT-PCR in the saliva compared to its presence in NP swabs. This can assess the performance of using a saliva sample as a screening tool for detecting SARS-CoV-2 Study Design. A cross-sectional study comparing the presence of SARS-CoV2 in NP swab and saliva samples in cases presenting to COVID-19 Clinic in the Bahrain defense force hospital. COVID-19 Clinic tests symptomatic individuals, staff, close contacts and pre-operation patients. All cases diagnosed as positive for SARS-CoV-2 were based on RT-PCR tests of nasopharyngeal samples. The nasopharyngeal samples were transferred to a viral transport media immediately after collection and transported to a COVID-19 laboratory for testing. The RT-PCR tests were conducted using Thermo Fisher Scientific (Waltham, MA) Invitrogen on the Applied Biosystems (Foster City, CA) 7500 Fast Dx RealTime PCR Instrument. The assay targeted the E gene. If positive, the sample was confirmed by RdRP and N genes. The E gene CT value was reported and used in this study. CT Values >40 were considered negative. • Patient were instructed not to drink, smoke or chew gum immediately beforehand. • at least 2.5ml of saliva sample was collected in saliva collection tube (not measuring froth.) • The patient will be instructed to spit into the tube. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint • Saliva production can be helped by placing the tip of the tongue behind the front teeth. • Saliva sample can be kept in fridge up to 72hours. Saliva samples were testing using PCR. The PCR protocol followed the same protocol used for the Nasopharyngeal sample Samples positive for one or two targets were considered equivocal. Sensitivity, specificity, positive and negative predictive values and their 95 % confidence intervals (CI) were calculated to assess diagnostic performance. Agreement between the NP sample and saliva sample for the virus detection ability was assessed using Cohen's Kappa (κ coefficient). Spearman correlation was used to assess the correlation between the cycle threshold (Ct) values of both the Saliva and NPS PCRs. Bland-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; Altman analysis was used to compare the Ct values between NPS and saliva. Differences in continuous variables were compared using a paired two sample t-test. All P-values were two-sided and P < 0.05 was considered significant. Statistical analyses were carried out using STATA 15.1 The protocol and manuscript for this study were reviewed and approved by the Research and Research Ethics Committee in the Bahrain Defense Force Hospital (Approval Code: BDF/R&REC/2020-494). All methods and retrospective analysis of data was approved by the Committee, and carried out in accordance with local and international guidelines and regulations. Informed consent was waived by the Research and Research Ethics Committee. A total of 1019 participants' samples were collected. Two samples were collected from each participant, NP and saliva samples. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint 2) . The Ct values from saliva and NP samples were positively correlated using spearman coefficient, however this correlation was non-significant (r= 0.3 p= 0.08). Figure 3 shows the Ct value correlation between saliva and NP samples. Total 15 72 87 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint The NP swab is considered the most reliable for PCR testing and diagnosis of SARS-CoV-2 infection [14] . NP is an invasive procedure, it is reported that this technique is uncomfortable, and it induces coughing, sneezing, and causes aerosolization which increases the risk for infection transmission. The collection of NP samples can also cause nasal bleeding [1] . It is even more difficult to perform NP swab in pediatric cases and those with special needs. This difficulty can lead to improper sampling and inaccurate diagnosis. Furthermore, patient can be reluctant or hesitant to undergo testing by NP sample given its invasiveness. Saliva testing is noninvasive, comfortable and can be performed by non-medical individuals with no intra or post-procedure complications. It could also be self-collected, without risk of close contact. Several studies examined the accuracy of saliva in detecting SARS-CoV-2. The findings varied in terms of agreement. Wyllie et al. demonstrated that saliva detected 81% of symptomatic admitted cases with COVID19 [15] . A crosse-sectional study conducted in Kuwait by Altawalah et al showed that saliva samples tested by PCR had a sensitivity of 83.43% in diagnosing symptomatic COVID19 cases in comparison to NP samples [14] . Another study by Williams et al. also reported similar findings [16] . The sensitivity of saliva sample in our study was 72.9%. This was slightly less when compared to other studies. This could be explained by the studied sample of cases. The cases within our study included a heterogenous sample of symptomatic, asymptomatic, close contacts, staff screening and pre-operative screening. The presence of asymptomatic positive individuals within our sample can explain the differences in the reported findings. As these individuals might have low viral loads. [17] The sensitivity of the saliva sample increased to 86.7% when restricted to symptomatic cases only. This is in agreement with the majority of the reports reference above. Yokota et al reported 86% sensitivity in using saliva samples to detect SARS-CoV-2 in asymptomatic individuals. However, the study included a full cohort of asymptomatic close contact to confirmed cases, who are considered a high-risk category [18] . The variation in the diagnostic performance of saliva samples can be due to different collection methods. Chen et al demonstrated that only 30% of infected cases were . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint detected using saliva [19] . Chen et al reported the salivary detection rate based on pure saliva fluid secreted from the opening of salivary gland canals [19] . In Other studies patients were asked to cough out saliva from their throat into sterile containers, and hence the saliva samples were mainly sputum from the lower respiratory tract. The variation in collection technique can account to the different findings [4] . The specificity of saliva PCR was high in our studied sample, 98.8%. This can be especially important when using saliva in low-risk individuals. The specificity is in agreement with multiple manuscripts [14, 16, 18] . However, given the potentially lower sensitivity in asymptomatic individuals. Saliva samples can produce more false negative tests in asymptomatic cases (e.g.: pre-operative screening). It is arguable though that these cases would have lower viral load and hence could be noninfectious [20] . The findings in our study showed that saliva sample have an acceptable agreement with NP samples. The CT values between both were not different, indicating that the viral loads were similar between saliva and nasopharyngeal samples. This is in agreement with a review conducted by Fakheran et al. as they reported that there is no statistically significant difference between nasopharyngeal and saliva samples regarding viral load [4] . Similarly, Yokota et al and altawalah also had similar findings [14, 18] In our study, the positive cases in both saliva and NP samples were too small to conduct a stratified correlation analysis. Further analysis to correlate saliva and NP . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint sample Ct values, stratified on symptom status and type of symptoms, are required to further understand this lack of correlation [20] . The study has several strengths. It included a heterogenous sample of 1009 patients. All cases had saliva and NP sample collected at the same time and analyzed in the same lab using the same standard technique. The limitations of the study included the absence of the clinical details and the low prevalence of the infection within the studied sample. The low number of positive cases limiting the strength of the study in assessing the diagnostic ability of saliva samples. Saliva samples could be best utilized for children; however, our study was performed in adult. Yet, the difference in age group is not expected to have significantly alter the results. The findings in our study adds to the rising evidence that saliva can be a reliable sample to screen for SARS-CoV-2 infection. This is especially important when it is difficult to collect NP samples. Saliva samples can be even more accurate when used in symptomatic individuals. Saliva samples are however at risk of producing more false negative tests. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint Saliva: potential diagnostic value and transmission of 2019-nCoV Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19 Saliva as a diagnostic specimen for detection of SARS-CoV-2 in suspected patients: a scoping review Association of chemosensory dysfunction and COVID-19 in patients presenting with influenzalike symptoms. International Forum of Allergy & Rhinology Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development Saliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community setting2020 17th Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clinical Chemistry and Laboratory Medicine Consistent Detection of 2019 Novel Coronavirus in Saliva. Clinical Infectious Diseases Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review. Reviews in Medical Virology Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A crosssectional study Journal of Clinical Virology Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. The New England Journal of Medicin Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity SARS-Cov-2 Viral Load as an Indicator for COVID-19 Patients' Hospital Stay Mass screening of asymptomatic persons for SARS-CoV-2 using saliva. Clinical Infectious Diseases Detection of 2019-nCoV in Saliva and Characterization of Oral Symptoms in COVID-19 Patients2020 Available from: Declarations Conflict of interest: The authors have declared that no conflict of interest exists. Ethics approval and consent to participate: The study was approved by the National COVID-19 Research and Ethics Committee Availability of data and materials: All the data for this study will be made available upon reasonable request to the corresponding author. Funding: No funding was received to perform this study AA and AIA analysed the data. AA, AB, AIA wrote the manuscript. AA and MQ interpreted data and edited the manuscript. All authors reviewed and approved the final version of the manuscript. Manaf Alqahtani is the guarantor of this work. Corresponding author: Manaf AlQahtani Email: mqahtani@rcsi-mub . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.07.20244681 doi: medRxiv preprint